ProShare Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.66M | Sell |
3,067
-620
| -17% | -$349K | ﹤0.01% | 707 |
|
|
2026
Q1 | $2.19M | Buy |
3,687
+58
| +2% | +$28.9K | ﹤0.01% | 686 |
|
|
2025
Q4 | $1.77M | Buy |
3,629
+94
| +3% | +$43.8K | ﹤0.01% | 709 |
|
|
2025
Q3 | $1.48M | Sell |
3,535
-147
| -4% | -$49.4K | ﹤0.01% | 729 |
|
|
2025
Q2 | $1.06M | Sell |
3,682
-247
| -6% | -$73.8K | ﹤0.01% | 801 |
|
|
2025
Q1 | $1.21M | Sell |
3,929
-274
| -7% | -$93.9K | ﹤0.01% | 762 |
|
|
2024
Q4 | $1.48M | Sell |
4,203
-4,935
| -54% | -$1.81M | ﹤0.01% | 768 |
|
|
2024
Q3 | $3.27M | Buy |
9,138
+4,308
| +89% | +$1.46M | 0.01% | 600 |
|
|
2024
Q2 | $1.54M | Sell |
4,830
-759
| -14% | -$201K | ﹤0.01% | 699 |
|
|
2024
Q1 | $1.28M | Buy |
5,589
+117
| +2% | +$26.4K | ﹤0.01% | 740 |
|
|
2023
Q4 | $1.2M | Sell |
5,472
-131
| -2% | -$30.2K | ﹤0.01% | 727 |
|
|
2023
Q3 | $1.27M | Sell |
5,603
-166
| -3% | -$38.2K | ﹤0.01% | 693 |
|
|
2023
Q2 | $1.27M | Sell |
5,769
-152
| -3% | -$33.7K | ﹤0.01% | 692 |
|
|
2023
Q1 | $1.33M | Sell |
5,921
-1,345
| -19% | -$332K | ﹤0.01% | 693 |
|
|
2022
Q4 | $2.02M | Buy |
7,266
+224
| +3% | +$56.5K | 0.01% | 625 |
|
|
2022
Q3 | $1.48M | Buy |
7,042
+283
| +4% | +$63.3K | 0.01% | 667 |
|
|
2022
Q2 | $1.59M | Sell |
6,759
-2,402
| -26% | -$488K | 0.01% | 684 |
|
|
2022
Q1 | $1.64M | Sell |
9,161
-2,379
| -21% | -$453K | ﹤0.01% | 764 |
|
|
2021
Q4 | $2.49M | Sell |
11,540
-2,229
| -16% | -$438K | ﹤0.01% | 717 |
|
|
2021
Q3 | $2.54M | Buy |
13,769
+712
| +5% | +$140K | 0.01% | 664 |
|
|
2021
Q2 | $2.34M | Buy |
13,057
+2,624
| +25% | +$500K | 0.01% | 687 |
|
|
2021
Q1 | $1.75M | Sell |
10,433
-715
| -6% | -$119K | 0.01% | 742 |
|
|
2020
Q4 | $1.69M | Buy |
11,148
+215
| +2% | +$28.2K | 0.01% | 685 |
|
|
2020
Q3 | $1.1M | Buy |
10,933
+265
| +2% | +$29.1K | 0.01% | 698 |
|
|
2020
Q2 | $1.29M | Buy |
10,668
+2,193
| +26% | +$247K | 0.01% | 645 |
|
|
2020
Q1 | $804K | Sell |
8,475
-5,788
| -41% | -$550K | 0.01% | 637 |
|
|
2019
Q4 | $1.26M | Sell |
14,263
-1,947
| -12% | -$171K | 0.01% | 730 |
|
|
2019
Q3 | $1.29M | Sell |
16,210
-1,134
| -7% | -$91.3K | 0.01% | 686 |
|
|
2019
Q2 | $1.35M | Sell |
17,344
-2,892
| -14% | -$270K | 0.01% | 676 |
|
|
2019
Q1 | $2.38M | Buy |
20,236
+1,271
| +7% | +$148K | 0.01% | 562 |
|
|
2018
Q4 | $2.06M | Sell |
18,965
-3,951
| -17% | -$458K | 0.01% | 563 |
|
|
2018
Q3 | $2.93M | Sell |
22,916
-146
| -0.6% | -$18.1K | 0.02% | 531 |
|
|
2018
Q2 | $2.61M | Sell |
23,062
-1,707
| -7% | -$188K | 0.02% | 570 |
|
|
2018
Q1 | $2.78M | Sell |
24,769
-3,426
| -12% | -$435K | 0.02% | 552 |
|
|
2017
Q4 | $4.17M | Sell |
28,195
-100
| -0.4% | -$12.7K | 0.03% | 458 |
|
|
2017
Q3 | $3.32M | Buy |
28,295
+1,085
| +4% | +$139K | 0.03% | 455 |
|
|
2017
Q2 | $3.53M | Sell |
27,210
-1,507
| -5% | -$188K | 0.04% | 429 |
|
|
2017
Q1 | $3.89M | Sell |
28,717
-4,027
| -12% | -$610K | 0.04% | 393 |
|
|
2016
Q4 | $4.7M | Buy |
32,744
+719
| +2% | +$91.8K | 0.05% | 351 |
|
|
2016
Q3 | $3.78M | Sell |
32,025
-6,354
| -17% | -$763K | 0.05% | 302 |
|
|
2016
Q2 | $4.07M | Sell |
38,379
-513
| -1% | -$57.2K | 0.05% | 283 |
|
|
2016
Q1 | $4.33M | Sell |
38,892
-3,712
| -9% | -$470K | 0.06% | 264 |
|
|
2015
Q4 | $6.67M | Buy |
42,604
+2,526
| +6% | +$368K | 0.08% | 240 |
|
|
2015
Q3 | $5.26M | Sell |
40,078
-5,190
| -11% | -$832K | 0.07% | 260 |
|
|
2015
Q2 | $7.87M | Sell |
45,268
-1,020
| -2% | -$183K | 0.11% | 194 |
|
|
2015
Q1 | $7.98M | Buy |
46,288
+4,846
| +12% | +$739K | 0.09% | 218 |
|
|
2014
Q4 | $5.37M | Sell |
41,442
-8,592
| -17% | -$1.11M | 0.06% | 308 |
|
|
2014
Q3 | $6.44M | Sell |
50,034
-636
| -1% | -$65.6K | 0.09% | 227 |
|
|
2014
Q2 | $4.48M | Buy |
50,670
+5,829
| +13% | +$561K | 0.06% | 332 |
|
|
2014
Q1 | $4.22M | Sell |
44,841
-11,731
| -21% | -$1.2M | 0.05% | 335 |
|
|
2013
Q4 | $6.4M | Buy |
56,572
+33,742
| +148% | +$3.04M | 0.1% | 216 |
|
|
2013
Q3 | $1.8M | Buy |
22,830
+9,671
| +73% | +$707K | 0.04% | 466 |
|
|
2013
Q2 | $866K | Buy |
+13,159
| New | +$848K | 0.02% | 942 |
|
Other funds holding UTHR
ACA
JT
ProShare Advisors's UTHR Position: Q2 2026 in Review
ProShare Advisors reduced its United Therapeutics (UTHR) stake by 17% in Q2 2026, selling an estimated $349K and leaving 3,067 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #707.
ProShare Advisors first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.98M in Q1 2015. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- ProShare Advisors held 3,067 shares of United Therapeutics worth $1.66M as of Q2 2026.
- ProShare Advisors sold 620 United Therapeutics shares in Q2 2026, an estimated $349K.
- United Therapeutics made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #707 holding.
- ProShare Advisors first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- ProShare Advisors's United Therapeutics position peaked at $7.98M in Q1 2015.
- 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.